Both the STOXX 50 and the STOXX 600 rose 0.2% on Monday, clawing back early losses after a broad risk-off mood rattled markets at the open. Investors refocused on corporate earnings, while expectations that Kevin Warsh, the Federal Reserve’s newly nominated chair, could usher in a more hawkish policy stance weighed on the dollar and pressured commodity markets. Fresh concerns over elevated AI valuations were also weighing. AstraZeneca gained nearly 2% after the company began trading on the New York Stock Exchange following a listing upgrade. Novartis rose 1.6%, Nestlé advanced 2.4%, SAP gained 1.1% and Unilever climbed 2.1%, while Capgemini added 1.2% after announcing the sale of its US subsidiary, Capgemini Government Solutions. On the downside, ASML Holding tumbled 2.8%, while mining, energy and defence stocks fell amid a sharp drop in commodity prices. Shell and TotalEnergies each declined 1.2%, Rheinmetall fell 1.6%, BP slipped 1.2%, Equinor dropped 2.1% and BAE Systems lost 2.2%.
